the unchelated nucleotides are very likely to be competitive inhibitors. Certainly in in vitro assays an excess of ATP over magnesium often has inhibitory effects, but this could also result if the unchelated ATP were preferentially to bind ions required by the enzyme.
But notice, also, that we have an equilibrium between all four forms which can be represented HATP3x = H+ + ATP4-
MgHATPI r H+ + MgATP2-Since the avidity of MgATP2-formation is more than 100 times that of MgHATP-, addition of Mg2+ to a mixture of HATP3-and ATP4-effectively increases its ionization; that is, we move from left to right, with consequent liberation of H+. Conversely, with limiting concentrations of Mg2+, change in pH will change not only the HATP3-/ATP4ratio but also the relative levels of the different MgATP complexes. This only applies with limiting amounts of Mg2+ because with excess cation at pH 7 everything is effectively pulled in thedirection of MgATP2 -. There is in fact more magnesium than ATP in the cell, but on the other hand ATP is not the only compound able to chelate magnesium, though it does so more strongly than most. Magnesium can also be bound by citrate and other carboxylic acids, ADP, AMP, inorganic phosphate and creatine phosphate, not to mention proteins and nucleic acids, and all these together are present in concentrations in excess of the total magnesium. Calculations (Kerson et al. 1967 ) and indirect observations (England et al. 1967 ) suggest that there is likely to be very little free Mg2+ present in the cell. Moreover, it is likely that what there is will be subject to variation by the demands of different metabolic conditions and, as pointed out, change in free Mg2+ will change amounts of chelate complexes from which a host of variations will follow. Thus, under physiological conditions, we have the possibility of a very complicated fluctuation in the concentrations of various chelate forms which are going to be subject to regulation by pH and could themselves affect the pool of H+. The more acid the intracellular pH (see, for example, papers by Butler et al. 1967, and Carter et al. 1967 , for differing estimates) the more complex the interactions. The possibilities for enzyme regulation are thus enormous.
One might have been forgiven for thinking a few years ago that metabolic pathways were well worked out. However, elucidation of the precise functioning of homeostatic control mechanisms raises a variety of new questions which should provide sufficient research to keep us all going for many years to come.
Mr S J H Ashcroft and Professor P J Randle (Department ofBiochemistry, University ofBristol) Control of Insulin Release by Glucose [Summary] An increase in the blood glucose concentration may be a major stimulus for insulin release (Yalow & Berson 1960) . The glucose effect is seen at concentrations above approximately 60 mg/ 100 ml and may be half maximal at about 180 mg/ 100 ml. In vitro studies of the effects of sugars other than glucose have suggested that only those sugars which are readily metabolized by mammalian tissues stimulate release. The glucose effect is suppressed by mannoheptulose (an inhibitor of hexokinase and glucokinase) but not by phloridzin (an inhibitor of glucose transporting systems). It has been suggested that the effector for insulin release may be a metabolite formed from glucose in pancreatic P-cells; and that the glucoreceptor (which determines the glucose concentration dependence) may be a hexokinase or glucokinase with a high Km for glucose (Coore & Randle 1964 , Grodsky et al. 1963 .
The effects of glucose concentration, mannoheptulose and phloridzin on the rate of oxidation of [U-14C] glucose to [14C] carbon dioxide have been investigated in mouse pancreatic islets prepared by collagenase digestion (Moskalewski 1965) . The oxidation of [U-14C] glucose was almost totally suppressed by mannoheptulose but was not influenced by phloridzin. Curves relating glucose oxidation rate to glucose concentration were either sigmoid or biphasic. Glucose concentration had relatively little effect on glucose oxidation rate below 100 mg/100 ml and above 180 mg/100 ml. On the other hand the rate of oxidation increased strikingly as the concentration of glucose was raised from 100 mg/100 ml to 180 mg/100 ml. The rate was half maximal at approximately 120 mg/100 ml. There is thus a correlation between the rate of oxidation of glucose in the islet and the effect of the sugar on release of insulin. It may be noted that the rate of glucose oxidation was particularly sensitive to changes in glucose concentration immediately above the fasting blood concentration (Ashcroft & Randle 1968a).
The properties of enzymes phosphorylating glucose in extracts of mouse islets prepared by ultrasonic vibration have been investigated with a radioactive assay. Glucokinase (which has a Km for glucose in tissues such as liver of approximately 300-400 mg/100 ml) was not detected in the islet homogenates. A hexokinase was detected with a Km for glucose which was 0 5 mg/100 ml at 5 mM ATP and 100 mg/100 ml at 0'1 mM ATP. The enzyme was competitively inhibited by mannoheptulose (Ashcroft & Randle 1968b). Preliminary measurements have indicated an islet ATP concentration of approximately 3 mM. If this hexokinase is the glucoreceptor in pancreatic islets then some other mechanism must raise its Km for glucose to approximately 120-180 mg/ 100 ml. Since the glucose Km is unusually dependent on ATP concentration the possibilities may include control of the affinity for ATP by other metabolites, for example, ADP and 5'-AMP.
